Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14877346 | 0.89 | KMT2A (0.41) | ACHECES2CES1CA1CA2 | |
| SCHEMBL1587526 | 0.83 | CYP2A6 (0.56) | CA1CA7CA9ALDH1A1CYP1A1 | |
| 1,3-Dimethoxybenzene SCHEMBL28114932 | 0.82 | CES2 (0.57) | ACHECES2CES1CYP3A4CA1 | |
| 1,3-Dimethoxybenzene SCHEMBL28217358 | 0.82 | ACHE (0.54) | ACHECES2CES1CYP3A4CA1 | |
| SCHEMBL2092735 | 0.81 | ALDH1A1 (0.58) | CYP3A4ALDH1A1CYP1A1CYP1A2CYP2E1 | |
| SCHEMBL29282086 | 0.81 | ABL1 (0.61) | CYP3A4LMNAMAOBCYP1A1CYP1A2 | |
| 1,3-Dimethoxybenzene SCHEMBL901285 | 0.81 | ACHE (0.70) | ACHECES2CES1CYP3A4CA1 | |
| 1,3-Dimethoxybenzene SCHEMBL9350 | 0.81 | ACHE (0.70) | ACHECES2CES1CYP3A4CA1 | |
| SCHEMBL535411 | 0.80 | ACHE (0.52) | ACHECES2CES1CYP3A4CA1 | |
| SCHEMBL28764686 | 0.79 | CYP1A2 (0.57) | ALDH1A1CYP1A1CYP1A2CYP2A6CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371309-A | Indenoacetates method for synthesizing compound | 南通大学 | 2025-01-28 | — | — | CN | claimed |
| CN-119371309-A | Indenoacetates method for synthesizing compound | 南通大学 | 2025-01-28 | — | — | CN | disclosed |
| CN-105431422-B | Isoindoline or isoquinoline compounds, process for their preparation and pharmaceutical compositions containing them | 法国施维雅药厂 | 2019-08-30 | — | — | CN | disclosed |
| CN-109456324-A | New isoindoline or isoquinoline compound, preparation method and the Pharmaceutical composition containing them | 法国施维雅药厂 | 2019-03-12 | — | — | CN | disclosed |
| CN-106414689-A | Perfume composition | 奇华顿股份有限公司 | 2017-02-15 | — | — | CN | disclosed |
| US-20150119606-A1 | Process for production of vanillin and vanillin derivatives | RHODIA OPERATIONS (FR) | 2015-04-30 | — | — | US | disclosed |
| EP-2847156-A1 | PROCESS FOR PRODUCTION OF VANILLIN AND VANILLIN DERIVATIVES | Rhodia Operations (FR) | 2015-03-18 | — | — | EP | disclosed |
| WO-2013166946-A1 | PROCESS FOR PRODUCTION OF VANILLIN AND VANILLIN DERIVATIVES | RHODIA OPERATIONS (FR) | 2013-11-14 | — | — | WO | disclosed |
| WO-2013166642-A1 | PROCESS FOR PRODUCTION OF VANILLIN AND VANILLIN DERIVATIVES | RHODIA OPERATIONS (FR) | 2013-11-14 | — | — | WO | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| US-4948777-A | CYANINE DYES | EASTMAN KODAK COMPANY (US) | 1990-08-14 | — | — | US | disclosed |
| US-4948776-A | Infrared absorbing chalcogenopyrylo-arylidene dyes for dye-donor element used in laser-induced thermal dye transfer | EASTMAN KODAK COMPANY (US) | 1990-08-14 | — | — | US | disclosed |
| US-4942141-A | Infrared absorbing squarylium dyes for dye-donor element used in laser-induced thermal dye transfer | EASTMAN KODAK COMPANY (US) | 1990-07-17 | — | — | US | disclosed |
| US-4912083-A | Dye containing azo group and morpholine and phenyl rings | EASTMAN KODAK COMPANY (US) | 1990-03-27 | — | — | US | disclosed |
| US-4864021-A | ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-09-05 | — | — | US | disclosed |
| EP-0323441-A2 | 5-Fluorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-07-05 | — | — | EP | disclosed |
| EP-0302441-A2 | Bis-styryl compounds | BASF Aktiengesellschaft (DE) | 1989-02-08 | — | — | EP | disclosed |
| EP-0180897-A2 | 5-Fluorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-14 | — | — | EP | disclosed |
| EP-0180188-A2 | A composition for increasing the anti-cancer activity of an anti-cancer compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-07 | — | — | EP | disclosed |
| US-4259350-A | PROTECTING DEGRADABLE ORGANIC MATERIAL FROM FUNGAL OR INSECT ATTACK | SANKYO COMPANY LIMITED (JP) | 1981-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119606-A1 | Process for production of vanillin and vanillin derivatives | UGDH, VARS1, SQLE | ACHE 1470/4885CES2 462/4885CES1 649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.